PAO Group, Inc has recently revitalized its mission to advance medical cannabis technologies with two complimenatry acquistions. One of a cannabis cultivation operation and one of a cannabis biopharmaceutical asset.
The cannabis biopharmaceutical asset, RespRx, is derived from a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCL...
PAO Group, Inc has recently revitalized its mission to advance medical cannabis technologies with two complimenatry acquistions. One of a cannabis cultivation operation and one of a cannabis biopharmaceutical asset.
The cannabis biopharmaceutical asset, RespRx, is derived from a patented botanical extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING ..." With the patented intellectual property (IP), to include the existing and ongoing research and development PAOG focuses on the development of pharmaceuticals to treat various illnesses, diseasesetc.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.